Barry H. Boise, a partner and vice chair of the firm’s Health Effects Litigation Practice Group, defends and counsels pharmaceutical, medical device and life sciences companies. He is the leader of the firm's State Attorney General Practice, is a leader of the firm’s multidisciplinary Life Sciences practice, and serves on the firm’s Finance and Alternative Fee Committees. He is a Fellow of the American Bar Foundation.
Mr. Boise's practice is concentrated in civil litigation, with a primary emphasis in the defense of pharmaceutical and medical device companies regarding marketed products, investigational new drugs, and medical devices. He has substantial experience litigating multidistrict litigation and coordinated state court litigation. Mr. Boise represents life science and health care companies in attorney general investigation and litigation, and in other civil and criminal actions involving health care fraud and abuse. His practice includes counseling regarding regulatory issues governing clinical trials and compliance in promotional and payor activities. He also advises clients regarding regulatory and litigation risks presented by pharmacogenomics or personalized medicine, as well as the launch of new products and emerging technologies in the mobile medical applications and health IT fields.
Mr. Boise is a frequent writer and speaker on matters affecting the life sciences industry, including litigation prevention, regulatory compliance and settlement strategies. He has presented at ACI's National Forum, the Pharmaceutical Regulatory and Compliance Congress, and MassBio among others, on a broad array of topics of interest to the life sciences community. He also is a member of organizations dedicated to the causes of his clients, including the Defense Research Institute and Lawyers for Civil Justice.